A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipeints

Transplantation Proceedings

Volumn 28, Issue 2, 1996, Pages 917-918

  Strata, R J ^a   Taylor, R J ^a   Weide, L G ^a   Sindhi, R ^a   Sudan, D ^a   Castaldo, P ^a   Cushing, K A ^a   Frisbie, K ^a   Radio, S J ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN; FLUCONAZOLE; KETOCONAZOLE; OKT 3; STEROID; THYMOCYTE ANTIBODY;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LUNG EDEMA; MALE; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANTILYMPHOCYTE SERUM; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KETOCONAZOLE; KIDNEY TRANSPLANTATION; MALE; MUROMONAB-CD3; PANCREAS TRANSPLANTATION; PROSPECTIVE STUDIES; PULMONARY EDEMA; RESPIRATORY DISTRESS SYNDROME, ADULT; SURVIVAL RATE;

EID: 0029932675     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)